Clinical Trial Update: Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of an HCV entry inhibitor in liver transplant recipients with hepatitis C infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HCV Entry Inhibitor

Snippet

Sponsor: Schiano, Thomas D., MD | Conditions: Hepatitis C Infection | Phase 1 | Status: TERMINATED